Top Page
Advance ZincTek Limited
(Sydney:ANO)
Advance ZincTek Limited (ANO) vs. iShares MSCI Australia ETF (EWA)
Advance ZincTek Limited Business Overview & Revenue Model
Advance ZincTek Limited Financial Statement Overview
| Breakdown | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 9.32M | 13.74M | 12.50M | 6.52M | 18.68M |
| Gross Profit | 4.46M | 3.62M | 3.91M | 1.57M | 8.44M |
| EBITDA | 252.00K | 3.82M | 5.10M | 1.33M | 8.03M |
| Net Income | -903.00K | 1.66M | 2.19M | 32.00K | 5.33M |
Balance Sheet | |||||
| Total Assets | 37.74M | 39.06M | 38.36M | 34.46M | 32.11M |
| Cash, Cash Equivalents and Short-Term Investments | 163.00K | 325.00K | 1.33M | 95.00K | 259.79K |
| Total Debt | 1.99M | 2.18M | 2.54M | 3.04M | 2.96M |
| Total Liabilities | 3.36M | 3.78M | 3.37M | 6.51M | 4.53M |
| Stockholders Equity | 34.38M | 35.28M | 34.99M | 27.96M | 27.57M |
Cash Flow | |||||
| Free Cash Flow | 31.00K | 1.61M | -1.59M | -2.65M | -3.65M |
| Operating Cash Flow | 2.24M | 4.42M | 1.62M | 1.39M | 120.06K |
| Investing Cash Flow | -2.21M | -3.49M | -2.17M | -4.04M | -3.77M |
| Financing Cash Flow | -193.00K | -1.93M | 1.78M | 2.48M | 3.56M |
Advance ZincTek Limited Technical Analysis
Advance ZincTek Limited Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | AU$57.63M | ― | -1.66% | ― | -25.16% | -157.23% | |
54 Neutral | AU$98.16M | ― | -182.18% | ― | ― | 45.43% | |
44 Neutral | AU$1.50B | -6.23 | -41.37% | 3.85% | -3.52% | -43.04% | |
40 Underperform | AU$70.10M | ― | -52.53% | ― | ― | 76.88% | |
39 Underperform | AU$41.44M | ― | -16.58% | ― | ― | -131.72% | |
32 Underperform | AU$51.55M | ― | -18.38% | ― | ― | 10.42% |
Advance ZincTek Limited Corporate Events
Advance ZincTek Limited (ANO) has responded to an ASX price query regarding unusual trading activity in its securities. The company stated that it is unaware of any undisclosed information that could explain the recent increase in share price and confirmed compliance with ASX Listing Rules. ANO emphasized that no trading has involved directors or officers due to a blackout period, and the response was approved by the board.
Advance ZincTek Limited (ANO) is currently unaffected by the new 200% tariffs imposed by the Trump Administration on Australian pharmaceutical companies, as zinc oxide remains exempt. ANO is considering the possibility of relocating to the USA if necessary, given its automated processes and ability to control equipment from Australia. The company does not anticipate any negative impact on its U.S. business, while its competitors in Japan and South Korea face significant tariffs.
Advance ZincTek Limited has reported a significant financial turnaround, with sales revenue for FY25 reaching $11.4 million, surpassing the previous year’s total. This growth is attributed to increased sales in the USA and operational efficiencies following the closure of its Perth facilities. The company anticipates a profit before tax of approximately $1.95 million, a notable improvement from the prior year’s loss. With a strong balance sheet, including cash reserves of $525,305 and no debt, the company is exploring capital management initiatives to be discussed at the upcoming Annual General Meeting.
Advance ZincTek Limited has announced the issuance of 36,344 fully paid ordinary securities on June 27, 2025, as part of an employee incentive scheme. This move is expected to enhance the company’s operational capabilities by aligning employee interests with corporate goals, potentially strengthening its market position and benefiting stakeholders.
Advance ZincTek Limited has announced a change in the director’s interest, specifically concerning Lev Mizikovsky. The director acquired 5,165 ordinary shares through an on-market trade, increasing his direct holdings to 165,361 shares, while his indirect holdings remain unchanged at 40,243,902 shares. This change reflects a minor adjustment in the director’s investment, with no significant implications for the company’s overall operations or market positioning.
Advance ZincTek Limited announced a change in the director’s interest, with Lev Mizikovsky acquiring 706 additional ordinary shares through an on-market trade. This change reflects a slight increase in Mizikovsky’s direct holdings, indicating continued confidence in the company’s prospects, which may reassure stakeholders about the company’s stability and future growth potential.
Advance ZincTek Limited reported a change in the director’s interest, with Lev Mizikovsky acquiring an additional 3,294 ordinary shares through an on-market trade. This change reflects a slight increase in the director’s direct holdings, potentially indicating confidence in the company’s future prospects.
Advance ZincTek Limited has announced a significant financial turnaround, expecting a profit before tax of approximately $1.75 million for FY25, compared to a loss of $990,000 in FY24. This improvement is attributed to increased sales in the USA and the closure of the Perth facilities, despite some negative impacts from non-recurring expenses and the loss of a major customer. The company remains debt-free with cash reserves of $767,095 and is exploring capital management initiatives. Product trials for high purity White Sapphire are set to begin, marking a strategic focus on expanding their market presence.